UNIVERSITY OF SOUTHERN CALIFORNIA
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1880-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://startusc.com
Continuous Infusion of Ropivacaine Hydrochloride in Reducing Pain After Surgery in Patients With Bladder Cancer
Phase 3
Withdrawn
- Conditions
- Bladder CarcinomaPost-operative Pain
- Interventions
- First Posted Date
- 2015-05-08
- Last Posted Date
- 2019-04-16
- Lead Sponsor
- University of Southern California
- Registration Number
- NCT02438852
- Locations
- 🇺🇸
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
PUBMIC (Prophylactic Use of Biologic Mesh in Ileal Conduit)
Not Applicable
Active, not recruiting
- Conditions
- HerniaBladder Carcinoma
- Interventions
- Other: Acellular Cadaveric Dermal Matrix
- First Posted Date
- 2015-05-08
- Last Posted Date
- 2024-02-15
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 110
- Registration Number
- NCT02439060
- Locations
- 🇺🇸
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project
Recruiting
- Conditions
- Major DepressionLate Life Depression (LLD)
- First Posted Date
- 2015-05-05
- Last Posted Date
- 2024-10-07
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 120
- Registration Number
- NCT02434393
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸University of Pittsburgh, Pittsburgh, Pennsylvania, United States
Sensory Adapted Dental Environments to Enhance Oral Care for Children
Not Applicable
- Conditions
- Autism
- Interventions
- Behavioral: Sensory Adapted Dental Environment
- First Posted Date
- 2015-04-29
- Last Posted Date
- 2021-05-11
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 220
- Registration Number
- NCT02430051
- Locations
- 🇺🇸
Children's Hospital Los Angeles, Los Angeles, California, United States
Combination Chemotherapy and Bevacizumab With or Without PRI-724 in Treating Patients With Newly Diagnosed Metastatic Colorectal Cancer
Phase 2
Withdrawn
- Conditions
- Stage IVB Colorectal CancerColorectal AdenocarcinomaStage IVA Colorectal Cancer
- Interventions
- Drug: CBP/beta-catenin Antagonist PRI-724Biological: BevacizumabDrug: Leucovorin CalciumDrug: OxaliplatinDrug: FluorouracilOther: Laboratory Biomarker Analysis
- First Posted Date
- 2015-04-10
- Last Posted Date
- 2017-04-17
- Lead Sponsor
- University of Southern California
- Registration Number
- NCT02413853
- Locations
- 🇺🇸
USC Norris Comprehensive Cancer Center, Los Angeles, California, United States
Celiac Plexus Block for Chronic Pancreatitis RCT
Not Applicable
Terminated
- Conditions
- PancreatitisPancreatitis, Chronic
- Interventions
- Procedure: Celiac Block with triamcinolone and bupivicaineProcedure: No Celiac BlockDrug: Intra Plexus Triamcinolone and Bupivicaine Injection
- First Posted Date
- 2015-03-26
- Last Posted Date
- 2018-02-14
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 1
- Registration Number
- NCT02399800
- Locations
- 🇺🇸
Los Angeles County Hospital, Los Angeles, California, United States
Real-Time Contrast-Enhanced Ultrasonography and Shear Wave Elastography in Predicting Treatment Response in Patients With Soft Tissue Sarcoma
Early Phase 1
Completed
- Conditions
- Bone SarcomaRetroperitoneal SarcomaAdult Soft Tissue Sarcoma
- Interventions
- Procedure: Real-Time CEUSProcedure: SWEDrug: Definity Suspension for InjectionDevice: Philips Shear Wave Elastography
- First Posted Date
- 2015-03-10
- Last Posted Date
- 2024-01-23
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 25
- Registration Number
- NCT02384473
- Locations
- 🇺🇸
USC Norris Comprehensive Cancer Center, Los Angeles, California, United States
Effects of Chemotherapy on Intestinal Bacteria in Patients With Newly Diagnosed Breast Cancer
Completed
- Conditions
- Stage IIB Breast CancerDuctal Breast Carcinoma In SituInvasive Breast CarcinomaStage I Breast CancerStage IIA Breast CancerStage IIIA Breast Cancer
- Interventions
- Other: Cytology Specimen Collection ProcedureOther: Laboratory Biomarker AnalysisOther: Questionnaire Administration
- First Posted Date
- 2015-02-24
- Last Posted Date
- 2019-06-18
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 36
- Registration Number
- NCT02370277
- Locations
- 🇺🇸
USC Norris Comprehensive Cancer Center, Los Angeles, California, United States
Molecular Characterization of CTCs and ctDNA in Blood and Plasma Samples From Patients With Metastatic and/or Hormone-Resistant Prostate Cancer
Terminated
- Conditions
- Metastatic Prostate CarcinomaHormone-Resistant Prostate Cancer
- Interventions
- Other: Laboratory Biomarker AnalysisOther: Cytology Specimen Collection Procedure
- First Posted Date
- 2015-02-24
- Last Posted Date
- 2017-04-17
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 24
- Registration Number
- NCT02370355
- Locations
- 🇺🇸
USC Norris Comprehensive Cancer Center, Los Angeles, California, United States
Questionnaires in Identifying Upper Extremity Function and Quality of Life After Treatment in Patients With Breast Cancer
Not Applicable
Terminated
- Conditions
- Musculoskeletal ComplicationStage IA Breast CancerStage IIA Breast CancerStage IIB Breast CancerStage IIIA Breast CancerStage IIIB Breast CancerStage IIIC Breast CancerStage IV Breast CancerTherapy-Related ToxicityRecurrent Breast Carcinoma
- Interventions
- Procedure: Quality-of-Life AssessmentOther: Questionnaire AdministrationOther: Medical Chart Review
- First Posted Date
- 2015-02-24
- Last Posted Date
- 2017-04-13
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 36
- Registration Number
- NCT02370264
- Locations
- 🇺🇸
USC Norris Comprehensive Cancer Center, Los Angeles, California, United States
© Copyright 2025. All Rights Reserved by MedPath